Minerva Neurosciences Competitors and Similar CompaniesClear all

Minerva Neurosciences's competitors and similar companies include Novartis, Regeneron Pharmaceuticals, Ajinomoto Bio-Pharma Services and R-Pharm.

	Minerva Neurosciences Minerva Neurosciences is a clinical-stage biopharmaceutical company.	Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products.	Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.	Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO).	R-Pharm R-Pharm is a pharmaceutical company.
Founding Date	Founding Date 2007	Founding Date 1996	Founding Date 1988	Founding Date 1998	Founding Date 2001
Type	Type Public	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech clinical research drug development pharma
Locations	Locations Waltham, US HQ	Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more	Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more	Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP	Locations Moskva, RU HQ Baku, AZ Illertissen, DE Lawrence Township, US
Employees	Employees 138% increase	Employees 75,883	Employees 15,1068% increase	Employees 68610% decrease	Employees 462
Valuation ($)	Valuation ($) 17.8 m	Valuation ($) N/A	Valuation ($) 102.2 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $56.7b (FY, 2025)	Revenue (est.) $14.3b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($293.4m) (FY, 2025)	Net income $14b (FY, 2025)	Net income $4.5b (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 51.2m	Total funding raised $ 6.5m	Total funding raised $ 53.9m	Total funding raised $ 3.5m	Total funding raised N/A